Equity · Healthcare
SNSE
NGMSensei Biotherapeutics (SNSE)
This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for SNSE to draw a line in its place.
Have Sensei Biotherapeutics (SNSE) insiders bought or sold shares recently?
SNSE has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 1 June 2026.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 01 Jun 2026 | Cambrian BioPharma Inc10% Owner | Sell | 25,000 | 501K USD |
| 01 Jun 2026 | Peyer James10% Owner | Sell | 25,000 | 501K USD |
| 07 Apr 2026 | MILLENNIUM MANAGEMENT LLC10% Owner | Buy | 1,108 | 37K USD |
| 07 Apr 2026 | MILLENNIUM MANAGEMENT LLC10% Owner | Sell | 8,151 | 253K USD |
| 06 Apr 2026 | MILLENNIUM MANAGEMENT LLC10% Owner | Buy | 1,104 | 34K USD |
| 06 Apr 2026 | MILLENNIUM MANAGEMENT LLC10% Owner | Sell | 1,259 | 39K USD |
| 02 Apr 2026 | MILLENNIUM MANAGEMENT LLC10% Owner | Buy | 2,003 | 70K USD |
| 02 Apr 2026 | MILLENNIUM MANAGEMENT LLC10% Owner | Sell | 7,666 | 246K USD |
| 01 Apr 2026 | MILLENNIUM MANAGEMENT LLC10% Owner | Buy | 6,175 | 213K USD |
| 01 Apr 2026 | MILLENNIUM MANAGEMENT LLC10% Owner | Sell | 1,150 | 36K USD |
| 31 Mar 2026 | MILLENNIUM MANAGEMENT LLC10% Owner | Buy | 6,005 | 169K USD |
| 31 Mar 2026 | MILLENNIUM MANAGEMENT LLC10% Owner | Sell | 1,591 | 41K USD |
| Bought | 8 open-market purchases | 46,980 | $1.34M | |
| Sold | 17 open-market sales | 128,881 | $2.28M |
Showing the 12 most recent of 25 open-market trades in this window. The figures above count all of them.
2 other filings: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 09 Dec 2025 | Cambrian BioPharma Inc | Option exercise | 395 | 3K USD |
| 09 Dec 2025 | Peyer James | Option exercise | 395 | 3K USD |
Which funds hold Sensei Biotherapeutics (SNSE)?
5 of the 45 institutional funds we track reported a Sensei Biotherapeutics position for the quarter ended 30 Jun 2026 — a combined 64.2M USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Baker Bros. Advisors | New position | 1,286,411 | 32.2M USD | |
| Balyasny Asset Management | Added | 1,042,198 | 26.1M USD | +6,331.3% |
| Marshall Wace | Added | 206,508 | 5.2M USD | +214.2% |
| Renaissance Technologies | Trimmed | 20,416 | 510K USD | −36.3% |
| Citadel Advisors | New position | 12,296 | 307K USD | |
| Millennium Management | Exited |
What has been filed or recorded for Sensei Biotherapeutics (SNSE)?
The filings we hold for Sensei Biotherapeutics, newest first: 6 quarterly earnings reports and 2 annual reports, the latest dated 31 Mar 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −131.45 USD | |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −16.72 USD | |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −3.62 USD | |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −3.91 USD | |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −5.45 USD | |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −24.01 USD | |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −5.77 USD | |
| 30 Jun 2024 | Quarterly earnings | Q2 2024 reported | EPS −5.69 USD |
Sensei Biotherapeutics (SNSE): frequently asked questions
Have Sensei Biotherapeutics insiders bought or sold shares recently?
No Sensei Biotherapeutics insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 1 Jun 2026 (SEC Form 4). See Insiders
Which funds own Sensei Biotherapeutics?
5 of the 45 funds we track reported a Sensei Biotherapeutics position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Baker Bros. Advisors, Balyasny Asset Management and Marshall Wace. See Funds
When did Sensei Biotherapeutics last report earnings?
Sensei Biotherapeutics last reported earnings on 31 Mar 2026 for Q1 2026, with EPS of −131.45 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SEC EDGARXBRL company facts
- SEC EDGARreported earnings figures and scheduled report dates